FIRST DEMONSTRATION OF THE POTENT AND SELECTIVE INHIBITORY EFFECT OF NOVEL SMALL MOLECULE ALK5 INHIBITOR (GW788388) IN DISRUPTION OF TGF-BETA/ALK5/SMAD SIGNALING IN KELOID DISEASE

被引：0
|
作者：
Syed, F. [1 ,2 ]
Bayat, A. [1 ,2 ]
机构：
[1] Manchester Inst Biotechnol, Manchester, Lancs, England
[2] Univ Hosp South Manchester NHS Fdn Trust, Manchester, Lancs, England
来源：
WOUND REPAIR AND REGENERATION | 2013年 / 21卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：A45 / A45
页数：1
相关论文
共 6 条
  • [1] Kaempferol 3-O-gentiobioside, an ALK5 inhibitor, affects the proliferation, migration, and invasion of tumor cells via blockade of the TGF-β/ALK5/Smad signaling pathway
    Zhang, Zihao
    Qiao, Yu
    Yang, Li
    Chen, Zuwang
    Li, Tao
    Gu, MingZhen
    Li, Chong
    Liu, Mingming
    Li, Rong
    PHYTOTHERAPY RESEARCH, 2021, 35 (11) : 6310 - 6323
  • [2] SELECTIVE INHIBITION OF TGF-BETA TYPE I RECEPTOR (ALK5) AMELIORATES RENAL TUBULOINTERSTITIAL FIBROSIS
    Yokoi, Hideki
    Mukoyama, Masashi
    Nagata, Manabu
    Sawai, Kazutomo
    Yoshioka, Tetsuno
    Saito, Yoko
    Nagae, Tetsuya
    Sugawara, Akira
    Nakao, Kazuwa
    NEPHROLOGY, 2005, 10 : A269 - A269
  • [3] GALUNISERTIB TGF-beta receptor type-1 (ALK5; SKR4) inhibitor Oncolytic
    Gras, J.
    DRUGS OF THE FUTURE, 2014, 39 (04) : 257 - 262
  • [4] Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma:: Smad activation is crucial for both the tumor suppressive and prometastatic function
    Schniewind, B.
    Groth, S.
    Mueerkoester, S. Sebens
    Sipos, B.
    Schaefer, H.
    Kalthoff, H.
    Faendrich, F.
    Ungefroren, H.
    ONCOGENE, 2007, 26 (33) : 4850 - 4862
  • [5] Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function
    B Schniewind
    S Groth
    S Sebens Müerköster
    B Sipos
    H Schäfer
    H Kalthoff
    F Fändrich
    H Ungefroren
    Oncogene, 2007, 26 : 4850 - 4862
  • [6] SKI2162, A NOVEL TRANSFORMING GROWTH FACTOR (TGF)-BETA TYPE I RECEPTOR KINASE (ALK5) INHIBITOR, ALLEVIATES PROFIBROTIC TGF-BETA1 RESPONSES IN FIBROBLASTS DERIVED FROM PEYRONIE'S PLAQUE
    Ryu, J. K.
    Piao, S.
    Choi, M. J.
    Tumurbaatar, M.
    Kim, W. J.
    Jin, H. R.
    Shin, S. H.
    Yim, G. N.
    Song, J. S.
    Kwon, M. H.
    Song, K. M.
    Suh, J. K.
    Song, Y. S.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 155 - 155
1